Overview

Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

Status:
Unknown status
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate predictors of response to antipsychotic medication in subjects with schizophrenia. The investigators will evaluate psychopathology,brain MRI, genetics and neuropsychological profile. Two groups of treatment will be compared: first generation antipsychotics vs. second generation antipsychotics. Participants will be randomized to one of the groups. Trial duration: 12 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Antipsychotic Agents
Chlorpromazine